Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Goodyear Tire & Rubber Co (GT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Goodyear Tire & Rubber Co — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Goodyear Tire & Rubber Co trades at $6.12 (market cap $1.75B). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 2.9× Goodyear Tire & Rubber Co's market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals.
| ACAD | GT | |
|---|---|---|
Market Cap | $5.07B | $1.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.41 | $10.54 |
52-Week Low | $20.06 | $5.58 |
Enterprise Value | $4.19B | $9.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →
